ELIGARD
These highlights do not include all the information needed to use ELIGARD safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002
b78d1919-9dee-44fa-90f9-e0a26d32481d
HUMAN PRESCRIPTION DRUG LABEL
Apr 29, 2019
TOLMAR Inc.
DUNS: 791156578
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Leuprolide Acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
Leuprolide Acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
Leuprolide Acetate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
Leuprolide Acetate
Product Details
FDA regulatory identification and product classification information